Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: Kamuvudine-9 (K9) in Diabetic Macular Edema [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Kamuvudine-9 (K9) for diabetic macular edema is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kamuvudine-9

Snippet

Sponsor: Dr. Bryan Strelow | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: RECRUITING